توسعه یک ترکیب ضد چاقی جدید با خواص مهار کننده در تجمع لیپیدها در سلولهای چربی 3T3-L1

پیاب, مولود and حسنی رنجبر, شیرین and بعیری, مریم and رحیمی فرد, مهبان and ارجمند, بابک and حقی امین جان, حامد and عبداللهی, محمد and لاریجانی, باقر (1399) توسعه یک ترکیب ضد چاقی جدید با خواص مهار کننده در تجمع لیپیدها در سلولهای چربی 3T3-L1. Iranian Biomedical Journal ــ 24 (3). pp. 155-163. شاپا 1028-852X


Official URL: http://ibj.pasteur.ac.ir/article-1-2968-en.html


Development of a Novel Anti-Obesity Compound with Inhibiting Properties on the Lipid Accumulation in 3T3-L1 Adipocytes

English Abstract

Background: Obesity as a developing global challenge can be characterized by increase in adipocyte number and size arising from adipogenesis. Control of adipogenesis, as a potential strategy, can prevent and manage obesity. So far, the effectiveness of herbal medicine and active ingredients therapies for obesity and metabolic syndrome treatment has been investigated. In this study, a novel combination of berberine, catechin, and capsaicin was developed, and their effect on 3T3-L1 adipocytes was investigated. Mthods: The effect of active ingredient on the cell viability was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Adipocytes were treated with various concentrations of berberine (3 and 6.25 μM), catechin (6.25 and 12.5 μM), and capsaicin (6.25 and 12.5 μM) alone and in combination. Results: All active ingredients did not affect the cell viability by MTT assay at different concentrations. The dual and triple combinations of three active ingredients showed excellent potential as anti-obese without any toxicity. The inhibitory effect of berberine, catechin, and capsaicin on the differentiation of 3T3-L1 preadipocytes was found to be dose-dependent. These results indicate that catechin in both doses may have a stronger effect than the two other active ingredients on the intracellular lipid accumulation. Also, the triple combination of the aforementioned ingredients showed better responses than their dual combination. Conclusion: This work is the first report to simultaneously investigate these three active ingredients in a single, dual, and triple formats. The berberine, catechin, and capsaicin co-treatment inhibits the adipogenesis during the differentiation process. This compound can be a prospective therapy for obesity and relevant diseases such as dyslipidemia. Keywords: Berberine; Capsaicin; Catechin; Obesity; 3T3-L1 cells.

Item Type:Article
زبان سند : انگلیسی
نویسنده اول :مولود پیاب
نویسنده مسئول :شیرین حسنی رنجبر
همکار طرح :مریم بعیری
همکار طرح :مهبان رحیمی فرد
همکار طرح :بابک ارجمند
نویسنده :حامد حقی امین جان
نویسنده :محمد عبداللهی
نویسنده مسئول :باقر لاریجانی
Additional Information:Indexed in: PubMed/Medline, Scopus, Embase
کلیدواژه ها (انگلیسی):Berberine, Capsaicin, Catechin, Obesity, 3T3-L1 cells
Subjects:QV pharmacology > QV 600 Toxicology
WD Nutrition Disease and metabolic diseases
Divisions:Vice Chancellor for Research and Technology > Pharmaceutical Sciences Research Center
ID Code:13186
Deposited By: Dr Hamed Haghi-Aminjan
Deposited On:04 May 1399 07:46
Last Modified:22 Mar 1400 11:04

Repository Staff Only: item control page

Document Downloads

More statistics for this item...